N.J. Admin. Code § 13:39-11B.1

Current through Register Vol. 56, No. 11, June 3, 2024

Section 13:39-11B.1 - Purpose and scope

(a) The rules in this subchapter regulate the practice of compounding antineoplastic agents and other hazardous substances for both sterile and non-sterile preparations and shall apply to all retail and institutional pharmacies that compound and dispense antineoplastic agents and other hazardous substances. The rules in this subchapter supplement those of N.J.A.C. 13:39-11 and 11A. To the extent the requirements for compounding antineoplastic agents and other hazardous substances are not specifically addressed in this subchapter, the requirements of N.J.A.C. 13:39-11 and 11A, as applicable, shall be followed.

(b) Effective on the effective date of USP 800 (currently, December 1, 2019), the compounding of antineoplastic agents and other hazardous substances shall be consistent with the standards established in USP 800, which is incorporated herein by reference, as amended and supplemented, and which is available for purchase at the United States Pharmacopeia website, www.usp.org.

Amended by R.2019 d.007, effective 1/7/2019.
See: 50 N.J.R. 1468(a), 51 N.J.R. 91(a).
In (b), substituted "on the effective date of USP 800 (currently, December 1, 2019)" for "July 1, 2018".